2020 annual financial data
Monte Rosa Therapeutics 2020 Net income growth
Direct answer
Net income growth was -347.54%.
Operating income was -28,010,000 USD and net income was -35,879,000 USD.
Operating cash flow was -23,053,000 USD.
Get free Monte Rosa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -28,010,000 USD
- Net income
- -35,879,000 USD
- Operating cash flow
- -23,053,000 USD